Department of Molecular and Cellular Pharmacology, Graduate School of Pharmaceutical Sciences, Nagoya City University.
Department of Physiology, Aichi Medical University.
Biol Pharm Bull. 2022 Nov 1;45(11):1684-1691. doi: 10.1248/bpb.b22-00513. Epub 2022 Aug 20.
Pulmonary arterial hypertension (PAH) is characterized by vascular remodeling of the pulmonary artery, which is mainly attributed to the excessive proliferation of pulmonary arterial smooth muscle cells (PASMCs) comprising the medial layer of pulmonary arteries. The activity of ion channels associated with cytosolic Ca signaling regulates the pathogenesis of PAH. Limited information is currently available on the role of Cl channels in PASMCs. Therefore, the functional expression of ClC3 channels/transporters was herein investigated in the PASMCs of normal subjects and patients with idiopathic pulmonary arterial hypertension (IPAH). Expression analyses revealed the upregulated expression of ClC3 channels/transporters at the mRNA and protein levels in IPAH-PASMCs. Hypoosmotic perfusion (230 mOsm) evoked swelling-activated Cl currents (I) in normal-PASMCs, whereas 100 µM 4,4'-diisothiocyanatostilbene-2,2'-disulfonic acid (DIDS) exerted the opposite effects. The small interfering RNA (siRNA) knockdown of ClC3 did not affect I. On the other hand, I was larger in IPAH-PASMCs and inhibited by DIDS and the siRNA knockdown of ClC3. IPAH-PASMCs grew more than normal-PASMCs. The growth of IPAH-PASMCs was suppressed by niflumic acid and DIDS, but not by 9-anthracenecarboxylic acid or T16A-A01. The siRNA knockdown of ClC3 also inhibited the proliferation of IPAH-PASMCs. Collectively, the present results indicate that upregulated ClC3 channels/transporters are involved in I and the excessive proliferation of IPAH-PASMCs, thereby contributing to the pathogenesis of PAH. Therefore, ClC3 channels/transporters have potential as a target of therapeutic drugs for the treatment of PAH.
肺动脉高压(PAH)的特征是肺动脉血管重构,这主要归因于构成肺动脉中层的肺动脉平滑肌细胞(PASMCs)的过度增殖。与细胞质 Ca 信号相关的离子通道的活性调节 PAH 的发病机制。目前关于 Cl 通道在 PASMCs 中的作用的信息有限。因此,本文研究了 ClC3 通道/转运体在正常人和特发性肺动脉高压(IPAH)患者的 PASMCs 中的功能表达。表达分析显示,在 IPAH-PASMCs 中 ClC3 通道/转运体的 mRNA 和蛋白水平上调。低渗灌注(230 mOsm)在正常-PASMCs 中引发肿胀激活的 Cl 电流(I),而 100 µM 4,4'-二异硫氰基二苯乙烯-2,2'-二磺酸(DIDS)则产生相反的效果。ClC3 的小干扰 RNA(siRNA)敲低不影响 I。另一方面,I 在 IPAH-PASMCs 中更大,并被 DIDS 和 ClC3 的 siRNA 敲低抑制。IPAH-PASMCs 的生长速度比正常-PASMCs 快。niflumic acid 和 DIDS 抑制 IPAH-PASMCs 的生长,但 9-蒽羧酸或 T16A-A01 则不然。ClC3 的 siRNA 敲低也抑制了 IPAH-PASMCs 的增殖。总之,这些结果表明,上调的 ClC3 通道/转运体参与 I 和 IPAH-PASMCs 的过度增殖,从而有助于 PAH 的发病机制。因此,ClC3 通道/转运体具有作为治疗 PAH 的治疗药物的靶标的潜力。